Max Robotics — Global Service Robot Directory + US Certification

About

Kenneth K. Lee is a pioneering surgeon-researcher whose work spans the frontiers of minimally invasive pancreatic surgery and neurorehabilitation technology. His primary research areas include robotic and laparoscopic pancreaticoduodenectomy, minimally invasive pancreatectomy for neuroendocrine tumors, and exoskeletal-assisted mobility for spinal cord injury patients. Dr. Lee’s landmark 2022 study on robotic pancreaticoduodenectomy (38 citations) demonstrated that robotic approaches yield significantly lower postoperative complications compared to laparoscopic methods, driving a paradigm shift toward increased robotic adoption in complex hepatobiliary surgery. His multi-institutional analysis of 1,023 patients undergoing minimally invasive pancreatectomy for pancreatic neuroendocrine tumors (24 citations) established critical benchmarks for perioperative outcomes in this high-risk population. Notably, Dr. Lee led the first randomized clinical trial examining home and community exoskeletal use in veterans with paralysis (2024, 16 citations), pioneering evidence that wearable robotics can restore functional ambulation outside clinical settings. His work uniquely bridges surgical innovation and rehabilitation engineering, with cumulative citations exceeding 78 across his most influential publications. Dr. Lee’s contributions have directly shaped clinical guidelines for minimally invasive pancreatic surgery while expanding possibilities for neural recovery through robotic exoskeletons—a dual impact that positions him at the intersection of surgical excellence and transformative assistive technology.